325 related articles for article (PubMed ID: 37321416)
1. Plight of CORMs: The unreliability of four commercially available CO-releasing molecules, CORM-2, CORM-3, CORM-A1, and CORM-401, in studying CO biology.
Bauer N; Yuan Z; Yang X; Wang B
Biochem Pharmacol; 2023 Aug; 214():115642. PubMed ID: 37321416
[TBL] [Abstract][Full Text] [Related]
2. Effects of frequently applied carbon monoxide releasing molecules (CORMs) in typical CO-sensitive model systems - A comparative in vitro study.
Stucki D; Krahl H; Walter M; Steinhausen J; Hommel K; Brenneisen P; Stahl W
Arch Biochem Biophys; 2020 Jul; 687():108383. PubMed ID: 32335048
[TBL] [Abstract][Full Text] [Related]
3. Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
Kramkowski K; Leszczynska A; Mogielnicki A; Chlopicki S; Fedorowicz A; Grochal E; Mann B; Brzoska T; Urano T; Motterlini R; Buczko W
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2149-57. PubMed ID: 22772756
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of CORM-2, CORM-3 and CORM-A1 on coagulation in human plasma.
Nielsen VG; Garza JI
Blood Coagul Fibrinolysis; 2014 Dec; 25(8):801-5. PubMed ID: 25058038
[TBL] [Abstract][Full Text] [Related]
5. Reassessing CORM-A1: redox chemistry and idiosyncratic CO-releasing characteristics of the widely used carbon monoxide donor.
Bauer N; Yang X; Yuan Z; Wang B
Chem Sci; 2023 Mar; 14(12):3215-3228. PubMed ID: 36970102
[TBL] [Abstract][Full Text] [Related]
6. CORM-A1: a new pharmacologically active carbon monoxide-releasing molecule.
Motterlini R; Sawle P; Hammad J; Bains S; Alberto R; Foresti R; Green CJ
FASEB J; 2005 Feb; 19(2):284-6. PubMed ID: 15556971
[TBL] [Abstract][Full Text] [Related]
7. Development of Triggerable, Trackable, and Targetable Carbon Monoxide Releasing Molecules.
Lazarus LS; Benninghoff AD; Berreau LM
Acc Chem Res; 2020 Oct; 53(10):2273-2285. PubMed ID: 32929957
[TBL] [Abstract][Full Text] [Related]
8. A thiol-reactive Ru(II) ion, not CO release, underlies the potent antimicrobial and cytotoxic properties of CO-releasing molecule-3.
Southam HM; Smith TW; Lyon RL; Liao C; Trevitt CR; Middlemiss LA; Cox FL; Chapman JA; El-Khamisy SF; Hippler M; Williamson MP; Henderson PJF; Poole RK
Redox Biol; 2018 Sep; 18():114-123. PubMed ID: 30007887
[TBL] [Abstract][Full Text] [Related]
9. Heme is required for carbon monoxide activation of mitochondrial BK
Rotko D; Bednarczyk P; Koprowski P; Kunz WS; Szewczyk A; Kulawiak B
Eur J Pharmacol; 2020 Aug; 881():173191. PubMed ID: 32422186
[TBL] [Abstract][Full Text] [Related]
10. Examining the antimicrobial activity and toxicity to animal cells of different types of CO-releasing molecules.
Nobre LS; Jeremias H; Romão CC; Saraiva LM
Dalton Trans; 2016 Jan; 45(4):1455-66. PubMed ID: 26673556
[TBL] [Abstract][Full Text] [Related]
11. Carbon monoxide and its donors - their implications for medicine.
Adach W; Olas B
Future Med Chem; 2019 Jan; 11(1):61-73. PubMed ID: 30526059
[TBL] [Abstract][Full Text] [Related]
12. Sensing a CO-Releasing Molecule (CORM) Does Not Equate to Sensing CO: The Case of DPHP and CORM-3.
Liu D; Yang X; Wang B
Anal Chem; 2023 Jun; 95(23):9083-9089. PubMed ID: 37263968
[TBL] [Abstract][Full Text] [Related]
13. Carbon monoxide releasing molecule 401 (CORM-401) modulates phase I metabolism of xenobiotics.
Walter M; Stahl W; Brenneisen P; Reichert AS; Stucki D
Toxicol In Vitro; 2019 Sep; 59():215-220. PubMed ID: 31004742
[TBL] [Abstract][Full Text] [Related]
14. Elucidation of the CO-Release Kinetics of CORM-A1 by Means of Vibrational Spectroscopy.
Klein M; Neugebauer U; Schmitt M; Popp J
Chemphyschem; 2016 Apr; 17(7):985-93. PubMed ID: 26699153
[TBL] [Abstract][Full Text] [Related]
15. On the Question of CO's Ability to Induce HO-1 Expression in Cell Culture: A Comparative Study Using Different CO Sources.
Yang X; Mao Q; Wang B
ACS Chem Biol; 2024 Mar; 19(3):725-735. PubMed ID: 38340055
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of platelet aggregation by carbon monoxide-releasing molecules (CO-RMs): comparison with NO donors.
Chlopicki S; Lomnicka M; Fedorowicz A; Grochal E; Kramkowski K; Mogielnicki A; Buczko W; Motterlini R
Naunyn Schmiedebergs Arch Pharmacol; 2012 Jun; 385(6):641-50. PubMed ID: 22362133
[TBL] [Abstract][Full Text] [Related]
17. Water-Soluble Carbon Monoxide-Releasing Molecules (CORMs).
Khan H; Faizan M; Niazi SUK; Madiha ; Muhammad N; Zhang W
Top Curr Chem (Cham); 2022 Dec; 381(1):3. PubMed ID: 36515756
[TBL] [Abstract][Full Text] [Related]
18. CO-independent modification of K
Gessner G; Sahoo N; Swain SM; Hirth G; Schönherr R; Mede R; Westerhausen M; Brewitz HH; Heimer P; Imhof D; Hoshi T; Heinemann SH
Eur J Pharmacol; 2017 Nov; 815():33-41. PubMed ID: 28987271
[TBL] [Abstract][Full Text] [Related]
19. Cell damage following carbon monoxide releasing molecule exposure: implications for therapeutic applications.
Winburn IC; Gunatunga K; McKernan RD; Walker RJ; Sammut IA; Harrison JC
Basic Clin Pharmacol Toxicol; 2012 Jul; 111(1):31-41. PubMed ID: 22269084
[TBL] [Abstract][Full Text] [Related]
20. Interaction of carbon monoxide-releasing ruthenium carbonyl CORM-3 with plasma fibronectin.
Aki T; Unuma K; Noritake K; Kurahashi H; Funakoshi T; Uemura K
Toxicol In Vitro; 2018 Aug; 50():201-209. PubMed ID: 29580987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
